Cutaneous T-cell lymphomas: the Sézary syndrome, mycosis fungoides, and related disorders.
暂无分享,去创建一个
A. Ahmed | P. Schein | M. Lutzner | R. Edelson | I. Green | C. Kirkpatrick | A. Ahmed
[1] T. Yoshida,et al. Migration inhibitory activity in serum and cell supernatants in patients with Sezary syndrome. , 1975, Journal of Immunology.
[2] P. Wiernik,et al. MANAGEMENT OF MYCOSIS FUNGOIDES—CURRENT STATUS AND FUTURE PROSPECTS , 1975, Medicine.
[3] L. Borella,et al. E receptors on blasts from untreated acute lymphocytic leukemia (ALL): comparison of temperature dependence of E rosettes formed by normal and leukemic lymphoid cells. , 1975, Journal of immunology.
[4] L. Thomas,et al. Mycosis fungoides: The pathology of extracutaneous involvement , 1974, Cancer.
[5] R. Blaese,et al. INFECTIOUS AGAMMAGLOBULINEMIA: TRANSMISSION OF IMMUNODEFICIENCY WITH GRAFTS OF AGAMMAGLOBULINEMIC CELLS , 1974, The Journal of experimental medicine.
[6] T. Waldmann,et al. Role of suppressor T cells in pathogenesis of common variable hypogammaglobulinaemia. , 1974, Lancet.
[7] D. Variakojis,et al. Mycosis fungoides: An ultrastructural study , 1974 .
[8] H. Rappaport,et al. Cytogenetic studies in mycosis fungoides , 1974, Cancer.
[9] P. Schein,et al. Successful management of the Sézary syndrome. Mobilization and removal of extravascular neoplastic T cells by leukapheresis. , 1974, The New England journal of medicine.
[10] Winkelmann Rk. Clinical studies of T-cell erythroderma in the Sezary syndrome. , 1974 .
[11] D. Zucker‐Franklin. Properties of the Sezary lymphoid cell. An ultrastructural analysis. , 1974, Mayo Clinic proceedings.
[12] E. Shevach,et al. Morphologic and functional properties of the atypical T lymphocytes of the Sezary syndrome. , 1974, Mayo Clinic proceedings.
[13] D. Stites,et al. ORIGIN OF HODGKIN'S CELL , 1974 .
[14] A. Prieur,et al. Membrane markers on chronic lymphocytic leukemia cells: A B cell leukemia with rosettes due to anti-sheep erythrocytes antibody activity of the membrane bound IgM and a T cell leukemia with surface Ig , 1974 .
[15] M. Lutzner,et al. Quantitative measurements of blood lymphocytes from patients with chronic lymphocytic leukemia and the Sézary syndrome. , 1974, Journal of the National Cancer Institute.
[16] R. Castellino,et al. Lymphography in mycosis fungoides , 1974, Cancer.
[17] D. Variakojis,et al. Mycosis fungoides: Pathologic findings in staging laparotomies , 1974, Cancer.
[18] E. Shevach,et al. Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Morphologic and functional studies. , 1974, Annals of internal medicine.
[19] R. Parmley,et al. IMMUNOHISTOCHEMICAL DEMONSTRATION OF IgG IN REED-STERNBERG AND OTHER CELLS IN HODGKIN'S DISEASE , 1974, The Journal of experimental medicine.
[20] T. Yoshida,et al. Serum migration-inhibitory activity in patients with lymphoproliferative diseases. , 1974, New England Journal of Medicine.
[21] H. Gralnick,et al. Nuclear topography in the abnormal cell of Sézary syndrome: observation by freeze-etch electron microscopy. , 1974, Journal of the National Cancer Institute.
[22] T. Yoshida,et al. Lymphokine activity in vivo in relation to circulating monocyte levels and delayed skin reactivity. , 1974, Journal of immunology.
[23] E. Shevach,et al. A human leukemia cell with both B and T cell surface receptors. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[24] C. Kirkpatrick,et al. Chemotactic activity in dialyzable transfer factor. , 1974, Proceedings of the National Academy of Sciences of the United States of America.
[25] R. Gershon. T cell control of antibody production. , 1974, Contemporary topics in immunobiology.
[26] Z. Fuks,et al. Prognostic signs and the management of the mycosis fungoides , 1973 .
[27] C. Coltman,et al. Therapy of mycosis fungoides with bleomycin , 1973, Cancer.
[28] G. Flandrin,et al. Indications of the thymus-derived nature of the proliferating cells in six patients with Sézary's syndrome. , 1973, The New England journal of medicine.
[29] M. Frank,et al. Identification of subpopulations of mononuclear cells in cutaneous infiltrates. I. Differentiation between B cells, T cells, and histiocytes. , 1973, The Journal of investigative dermatology.
[30] R. Winkelmann,et al. Erythroderma with atypical lymphocytes. (Sézary syndrome). , 1973, The American journal of medicine.
[31] E. V. Van Scott,et al. Complete remissions of mycosis fungoides lymphoma induced by topical nitrogen mustard (HN2). Control of delayed hypersensitivity to HN2 by desensitization and by induction of specific immunologic tolerance , 1973, Cancer.
[32] Z. Bentwich,et al. Lymphocyte binding of aggregated IgG and surface Ig staining in chronic lymphocytic leukaemia. , 1973, Clinical and experimental immunology.
[33] I. Emerit,et al. Cytogenetic, cytophotometric, and ultrastructural study of large cerebriform cells of the Sézary syndrome and description of a small-cell variant. , 1973, Journal of the National Cancer Institute.
[34] V. Nussenzweig,et al. Leukemic cells with membrane properties of thymus-derived (T) lymphocytes in a case of Sézary's syndrome: morphologic and immunologic studies. , 1973, Clinical immunology and immunopathology.
[35] V. P. Eijsvoogel,et al. The nature of the transforming lymphocyte in chronic lymphocytic leukemia , 1973 .
[36] Hansen Mm. Chronic lymphocytic leukaemia. Clinical studies based on 189 cases followed for a long time. , 1973 .
[37] J. Preud’homme,et al. Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. , 1972, Blood.
[38] C. Kirkpatrick,et al. Effect of transfer factor on lymphocyte function in anergic patients. , 1972, The Journal of clinical investigation.
[39] L. Díaz-Flores,et al. CYTOLOGY OF THE MYCOSIS FUNGOIDES AND THE SÉZARY SYNDROME , 1972, The British journal of dermatology.
[40] L. Old,et al. SEROLOGICALLY DEMONSTRABLE ALLOANTIGENS OF MOUSE EPIDERMAL CELLS , 1972, The Journal of experimental medicine.
[41] S. Hellman,et al. Pathogenesis of Hodgkin's disease. , 1972, Lancet.
[42] M. Lutzner,et al. MYCOSIS FUNGOIDES: Survival, Prognostic Features, Response to Therapy, and Autopsy Findings , 1972, Medicine.
[43] R. Schrek. Ultrastructure of blood lymphocytes from chronic lymphocytic and lymphosarcoma cell leukemia. , 1972, Journal of the National Cancer Institute.
[44] G. Achten,et al. Bleomycin in mycosis fungoides and reticulum cell lymphoma. , 1971, Archives of dermatology.
[45] R. Mcmillan,et al. Lymphocytes and the immune response. I. , 1971, The New England journal of medicine.
[46] B. Flaxman,et al. Nonspecificity of characteristic cells in mycosis fungoides. , 1971, Archives of dermatology.
[47] R. Gatti,et al. Serum inhibitors of lymphocyte responses. , 1971, Lancet.
[48] J. W. Hobbs,et al. Ultrastructure of abnormal cells in Sezary syndrome, mycosis fungoides, and parapsoriasis en plaque. , 1971, Archives of dermatology.
[49] P. Calabresi,et al. Azaribine for mycosis fungoides. , 1971, Archives of dermatology.
[50] P. Vincent,et al. The Sézary syndrome: cytogenetic studies and identification of the Sézary Cell as an abnormal lymphocyte. , 1971, The American journal of medicine.
[51] M. Frank,et al. The effect of temperature on the reactivity of guinea-pig complement with gamma G and gamma M haemolytic antibodies. , 1970, Immunology.
[52] R. Good. Progress Toward A Cellular Engineering , 1970 .
[53] V. Nussenzweig,et al. Tissue localization of lymphocytes bearing a membrane receptor for antigen-antibody-complement complexes. , 1970, Proceedings of the National Academy of Sciences of the United States of America.
[54] T. Murad,et al. Ultrastructure of mycosis fungoides , 1970, Cancer.
[55] R. Seeger,et al. SYNERGISTIC INTERACTION OF MACROPHAGES AND LYMPHOCYTES IN ANTIGEN-INDUCED TRANSFORMATION OF LYMPHOCYTES , 1970, The Journal of experimental medicine.
[56] C. Abell,et al. Effects of phytohemagglutinin and isoproterenol on DNA synthesis in lymphocytes from normal donors and patients with chronic lymphocytic leukemia. , 1970, Cancer research.
[57] D. McFarlin,et al. Impaired lymphocyte transformation in ataxia-telangiectasia in part due to a plasma inhibitory factor. , 1969, Journal of immunology.
[58] H. Claman,et al. Immunologic Complementation between Thymus and Marrow Cells—A Model for the Two‐Cell Theory of Immunocompetence , 1969, Transplantation reviews.
[59] E. J. Field,et al. Lymphocyte transformation in multiple sclerosis. Inhibition of unstimulated thymidine uptake by a serum factor. , 1968, Lancet.
[60] M. Lutzner,et al. The ultrastructure of an abnormal cell in Sézary's syndrome. , 1968, Blood.
[61] E. M. Pantelouris,et al. Absence of Thymus in a Mouse Mutant , 1968, Nature.
[62] W. L. Macaulay. Lymphomatoid papulosis. A continuing self-healing eruption, clinically benign--histologically malignant. , 1968, Archives of dermatology.
[63] M. Silk. Effect of plasma from patients with carcinoma on in vitro lymphocyte transformation , 1967, Cancer.
[64] P. Carbone,et al. Normal immunologic reactivity in patients with the lymphoma mycosis fungoides , 1966, Cancer.
[65] R. Bottomley,et al. Lactic dehydrogenase of human chronic lymphocytic leukemic leukocytes. , 1966, Blood.
[66] R. H. Levin,et al. Separation and collection of leukocytes. , 1965, Cancer research.
[67] L. Tedeschi,et al. Sézary syndrome. A malignant leukemic reticuloendotheliosis. , 1965, Archives of dermatology.
[68] G. Brecher,et al. Mycosis Fungoides: Relationship to Malignant Cutaneous Reticulosis and the Sézary Syndrome , 1964 .
[69] A. Eisen,et al. Mycosis fungoides: Natural history and aspects of its relationship to other malignant lymphomas , 1963 .
[70] R. Winkelmann,et al. Sezary syndrome--a malignant reticulemic erythroderma. , 1961, JAMA.
[71] H. B. Goodall,et al. SÉZARY'S SYNDROME. , 1959, The British journal of dermatology.
[72] E. Epstein,et al. DERMATOLOGIC MANIFESTATIONS OF THE LYMPHOBLASTOMA-LEUKEMIA GROUP , 1937 .